指南与共识细菌感染、耐药与抗菌药物医院感染防控

ESCMID/EUCIC 临床实践指南:多重耐药革兰阴性菌定植患者术前围手术期抗生素预防

ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
指南 / 共识 · Clin Microbiol Infect · 2022-12-22

该指南由 ESCMID/EUCIC 制定,针对成人住院患者术前多重耐药革兰阴性菌(MDR-GNB)定植者,系统综述截至 2022 年 4 月 30 日的文献,采用 GRADE 分级,就围手术期抗生素预防(PAP)给出推荐。多数推荐证据等级低,仅对氟喹诺酮耐药肠杆菌目经直肠前列腺活检、超广谱头孢菌素耐药肠杆菌目结直肠手术和实体器官移植条件性推荐直肠筛查和目标性 PAP;CRE 和 CRAB 筛查建议在移植术前评估局部流行病学后考虑。

要点

  • 条件性推荐:氟喹诺酮耐药肠杆菌目定植者经直肠超声引导前列腺活检前,行直肠筛查并给予目标性 PAP。
  • 条件性推荐:超广谱头孢菌素耐药肠杆菌目定植者行结直肠手术和实体器官移植前,行直肠筛查并给予目标性 PAP。
  • 建议(弱推荐):移植术前评估局部流行病学后,筛查碳青霉烯耐药肠杆菌目(CRE)和碳青霉烯耐药鲍曼不动杆菌(CRAB)。

核心结论

  • 指南针对 MDR-GNB 定植成人住院患者术前 PAP 给出推荐,多数推荐基于低级别证据,专家组条件性推荐对特定耐药菌定植者在特定手术前行直肠筛查和目标性 PAP。

研究设计与样本

  • ESCMID/EUCIC 基于系统综述制定循证指南,纳入研究覆盖超广谱头孢菌素耐药肠杆菌目、CRE、氨基糖苷类耐药肠杆菌目、氟喹诺酮耐药肠杆菌目、复方磺胺甲噁唑耐药嗜麦芽窄食单胞菌、CRAB、极端耐药铜绿假单胞菌、黏菌素耐药革兰阴性菌和泛耐药革兰阴性菌。
  • 主要结局为任何细菌和/或定植 MDR-GNB 所致手术部位感染(SSI)的发生及 SSI 归因死亡;重要结局包括任何术后感染并发症、全因死亡和 PAP 不良事件(含术后目标性 PAP 耐药发生和艰难梭菌感染发生率)。
  • 所有数据库最后检索截至 2022 年 4 月 30 日;证据等级和推荐强度按 GRADE 方法定义,由多学科专家组达成共识,推荐制定纳入抗菌药物管理考量。

主要发现

  • 指南专家组按细菌审查了 MDR-GNB 定植患者术前 SSI 风险的证据并批判性评价现有研究,发现显著知识空白,多数问题由观察性研究回答。
  • 检索到的研究存在中至高度偏倚风险,大多数推荐由低级别证据支持。

关键数值与推荐

  • 条件性推荐:氟喹诺酮耐药肠杆菌目定植者经直肠超声引导前列腺活检前,行直肠筛查并给予目标性 PAP。
  • 条件性推荐:超广谱头孢菌素耐药肠杆菌目定植者行结直肠手术和实体器官移植前,行直肠筛查并给予目标性 PAP。
  • 建议(弱推荐):移植术前评估局部流行病学后,筛查 CRE 和 CRAB。
  • 实施筛查程序或改变 PAP 前,需仔细考虑实验室工作量并纳入抗菌药物管理团队。

临床怎么用

  • 对氟喹诺酮耐药肠杆菌目定植者经直肠超声引导前列腺活检前,可考虑直肠筛查和目标性 PAP(条件性推荐)。
  • 对超广谱头孢菌素耐药肠杆菌目定植者行结直肠手术和实体器官移植前,可考虑直肠筛查和目标性 PAP(条件性推荐)。
  • 移植术前评估局部流行病学后,建议(弱推荐)筛查 CRE 和 CRAB。
  • 实施筛查程序或改变 PAP 前,需考虑实验室工作量并纳入抗菌药物管理团队。

局限性

  • 指南指出存在显著知识空白,多数问题由观察性研究回答。
  • 检索到的研究存在中至高度偏倚风险。
  • 大多数推荐由低级别证据支持。
  • 指南倡导开展高质量前瞻性研究评估 CRE 和 CRAB 定植者接受高危手术时 PAP 的影响。
  • 指南倡导未来精心设计的临床试验评估目标性 PAP 的有效性,包括通过术后培养使用欧洲抗菌药物敏感性试验委员会临床折点监测 MDR-GNB 定植。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SCOPE: The aim of the guidelines is to provide recommendations on perioperative antibiotic prophylaxis (PAP) in adult inpatients who are carriers of multidrug-resistant Gram-negative bacteria (MDR-GNB) before surgery. METHODS: These evidence-based guidelines were developed after a systematic review of published studies on PAP targeting the following MDR-GNB: extended-spectrum cephalosporin-resistant Enterobacterales, carbapenem-resistant Enterobacterales (CRE), aminoglycoside-resistant Enterobacterales, fluoroquinolone-resistant Enterobacterales, cotrimoxazole-resistant Stenotrophomonas maltophilia, carbapenem-resistant Acinetobacter baumannii (CRAB), extremely drug-resistant Pseudomonas aeruginosa, colistin-resistant Gram-negative bacteria, and pan-drug-resistant Gram-negative bacteria. The critical outcomes were the occurrence of surgical site infections (SSIs) caused by any bacteria and/or by the colonizing MDR-GNB, and SSI-attributable mortality. Important outcomes included the occurrence of any type of postsurgical infectious complication, all-cause mortality, and adverse events of PAP, including development of resistance to targeted (culture-based) PAP after surgery and incidence of Clostridioides difficile infections. The last search of all databases was performed until April 30, 2022. The level of evidence and strength of each recommendation were defined according to the Grading of Recommendations Assessment, Development and Evaluation approach. Consensus of a multidisciplinary expert panel was reached for the final list of recommendations. Antimicrobial stewardship considerations were included in the recommendation development. RECOMMENDATIONS: The guideline panel reviewed the evidence, per bacteria, of the risk of SSIs in patients colonized with MDR-GNB before surgery and critically appraised the existing studies. Significant knowledge gaps were identified, and most questions were addressed by observational studies. Moderate to high risk of bias was identified in the retrieved studies, and the majority of the recommendations were supported by low level of evidence. The panel conditionally recommends rectal screening and targeted PAP for fluoroquinolone-resistant Enterobacterales before transrectal ultrasound-guided prostate biopsy and for extended-spectrum cephalosporin-resistant Enterobacterales in patients undergoing colorectal surgery and solid organ transplantation. Screening for CRE and CRAB is suggested before transplant surgery after assessment of the local epidemiology. Careful consideration of the laboratory workload and involvement of antimicrobial stewardship teams before implementing the screening procedures or performing changes in PAP are warranted. High-quality prospective studies to assess the impact of PAP among CRE and CRAB carriers performing high-risk surgeries are advocated. Future well-designed clinical trials should assess the effectiveness of targeted PAP, including the monitoring of MDR-GNB colonization through postoperative cultures using European Committee on Antimicrobial Susceptibility Testing clinical breakpoints.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Righi E, Mutters NT, Guirao X, et al. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery. Clin Microbiol Infect. 2022. PMID: 36566836. doi:10.1016/j.cmi.2022.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。